Validation of post-induction Curie scores in high risk neuroblastoma. A Children's Oncology Group (COG) and SIOPEN group report on SIOPEN/HR-NBL1.

about

Validation of the mIBG skeletal SIOPEN scoring method in two independent high-risk neuroblastoma populations: the SIOPEN/HR-NBL1 and COG-A3973 trials.Neuroblastoma: clinical and biological approach to risk stratification and treatment.

P2860

Q44123857-95AA8053-0975-41FD-851A-BBF895CE406E Q52639269-FF08DE0B-C5C0-42B1-8B1F-278137A77DA5

P2860

Validation of post-induction Curie scores in high risk neuroblastoma. A Children's Oncology Group (COG) and SIOPEN group report on SIOPEN/HR-NBL1.

Item

http://www.wikidata.org/entity/Q40050078

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Validation of post-induction C ...... roup report on SIOPEN/HR-NBL1.

@en

type

Item

label

Validation of post-induction C ...... roup report on SIOPEN/HR-NBL1.

@en

prefLabel

Validation of post-induction C ...... roup report on SIOPEN/HR-NBL1.

@en

P1476

Validation of post-induction C ...... roup report on SIOPEN/HR-NBL1.

@en

P2093

Anna Kaminska

http://www.w3.org/2001/XMLSchema#string

Ariane Boubaker

http://www.w3.org/2001/XMLSchema#string

Arlene Naranjo

http://www.w3.org/2001/XMLSchema#string

Aurore Oudoux

http://www.w3.org/2001/XMLSchema#string

Barry L Shulkin

http://www.w3.org/2001/XMLSchema#string

Bieke Lambert

http://www.w3.org/2001/XMLSchema#string

Gregory A Yanik

http://www.w3.org/2001/XMLSchema#string

Helen Nadel

http://www.w3.org/2001/XMLSchema#string

Julie R Park

http://www.w3.org/2001/XMLSchema#string

Katherine K Matthay

http://www.w3.org/2001/XMLSchema#string

P2860

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma

Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a children's oncology group study

Semiquantitative mIBG scoring as a prognostic indicator in patients with stage 4 neuroblastoma: a report from the Children's oncology group.

Randomized Trial of prophylactic granulocyte colony-stimulating factor during rapid COJEC induction in pediatric patients with high-risk neuroblastoma: the European HR-NBL1/SIOPEN study.

Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.

Scintigraphic localization of pheochromocytoma.

High-dose rapid and standard induction chemotherapy for patients aged over 1 year with stage 4 neuroblastoma: a randomised trial.

Clinical and biologic features predictive of survival after relapse of neuroblastoma: a report from the International Neuroblastoma Risk Group project

Comparison of ¹²³I-metaiodobenzylguanidine (MIBG) and ¹³¹I-MIBG semi-quantitative scores in predicting survival in patients with stage 4 neuroblastoma: a report from the Children's Oncology Group

P31

scholarly article

P356

10.2967/JNUMED.117.195883

http://www.w3.org/2001/XMLSchema#string

P407

English

P50

Dominique Valteau-Couanet

P577

2017-09-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28887399

http://www.w3.org/2001/XMLSchema#string

P932

5868501

http://www.w3.org/2001/XMLSchema#string

Validation of post-induction Curie scores in high risk neuroblastoma. A Children's Oncology Group (COG) and SIOPEN group report on SIOPEN/HR-NBL1.

about

P2860

P2860

Validation of post-induction Curie scores in high risk neuroblastoma. A Children's Oncology Group (COG) and SIOPEN group report on SIOPEN/HR-NBL1.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P407

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P31

P356

P407

P50

P577

P698

P932